IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS

Clinical trials for IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS explained in plain language.

Never miss a new study

Get alerted when new IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS trials appear

Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a new pill tame cancer Drug's harsh gut side effects?

Disease control Terminated

This study aimed to see if adding the drug etrasimod to standard steroid treatment could better control severe diarrhea and colon inflammation (colitis) caused by powerful cancer immunotherapies. It planned to enroll adults with advanced cancer who developed this serious side eff…

Matched conditions: IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS

Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS

Get alerted when new IMMUNE CHECKPOINT INHIBITOR-RELATED DIARRHEA AND COLITIS trials appear

Could a new pill tame cancer Drug's harsh gut side effects?